Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
British Association for Sexual Health and HIV. UK national guideline for the management of pelvic inflammatory disease. June 2011. http://www.bashh.org/guidelines (last accessed 16 March 2016).
Ross J, Judlin P, Nilas L. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2007;18:662-666.
1. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
2. Grodstein F, Rothman KJ. Epidemiology of pelvic inflammatory disease. Epidemiology. 1994;5:234-242.
3. Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician. 2006;73:859-864.
4. Sutton MY, Strenberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States 1985-2001. Sex Trans Dis. 2005;32:778-784.
5. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362-1366.
6. Dayan L. Pelvic inflammatory disease. Aust Fam Physician. 2006;35:858-862.
7. Centers for Disease Control and Prevention. Self-study STD module: PID. October 2014. http://www.cdc.gov/ (last accessed 17 March 2016).
8. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004;82:454-461.
9. Ness RB, Randall H, Richter HE, et al. Pelvic Inflammatory Disease Evaluation and Clinical Health Study Investigators. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004;94:1327-1329.
10. McCormack, WM. Pelvic inflammatory disease. N Engl J Med. 1994;330:115-119.
11. Scholes D, Daling JR, Stergachis AS. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health. 1992;82:1352-1355.
12. Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol. 1990;162:639-644.
13. Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect. 2000;76:80-87.
14. Simms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect. 2006;82:452-457.
15. US Preventive Services Task Force. Screening for chlamydial infection: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147:128-134.
16. British Association for Sexual Health and HIV. UK national guideline for the management of pelvic inflammatory disease. June 2011. http://www.bashh.org/guidelines (last accessed 16 March 2016).
17. Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol. 2001;184:856-863.
18. Horrow MM. Ultrasound of pelvic inflammatory disease. Ultrasound Q. 2004;2:171-179.
19. Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol. 2009;52:2-20.
20. Yudin MH, Hillier SL, Wiesenfeld HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol. 2003;188:318-323.
21. British Association for Sexual Health; HIV/Medical Foundation for Aids & Sexual Health. Standards for the management of sexually transmitted infections. January 2010. http://www.bashh.org/ (last accessed 17 March 2016).
22. Ross J, Judlin P, Nilas L. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2007;18:662-666.
23. Molander P, Sjoberg J, Paavonen J, et al. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol. 2001;17:233-238.
24. Balthazar EJ, Birnbaum BA, Yee J, et al. Acute appendicitis: CT and US correlation in 100 patients. Radiology. 1994;190:31-35.
25. Low N, Bender N, Nartey L, et al. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2009;38:435-448.
26. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med. 2001;20:95-107.
27. Roberts TE, Robinson S, Barton PM, et al. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. BMJ. 2007;335:291.
28. Taylor BD, Haggerty CL. Management of chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect Drug Resist. 2011;4:19-29.
29. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642.
30. Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178:484-492.
31. Boukes FS, Dekker JH, Wiersma TJ, et al. Nederlands Huisartsen Genootschap. [Summary of the practice guideline 'Pelvic inflammatory disease' (first revision) from the Dutch College of General Practitioners] [in Dutch]. Ned Tijdschr Geneeskd. 2007;151:753-756.
32. Lazaro N. Sexually transmitted infections in primary care 2013 (RCGP/BASHH). 2013. http://www.rcgp.org (last accessed 17 March 2016).
33. Ross J. Pelvic inflammatory disease. Clin Evid. 2006;15:2176-2182.
34. Terao M, Koga K, Fujimoto A, et al. Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease. J Obstet Gynaecol Res. 2014;40:495-500.
35. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obstet Gynecol. 2012;55:893-903.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台